Bioaccessibility of Arsenic Bound to Corundum Using a Simulated Gastrointestinal System

2006 ◽  
Vol 3 (3) ◽  
pp. 208 ◽  
Author(s):  
Douglas G. Beak ◽  
Nicholas T. Basta ◽  
Kirk G. Scheckel ◽  
Samuel J. Traina

Environmental Context. Ingestion of soil contaminated with arsenic is an important pathway for human exposure to arsenic. The risk posed by ingestion of arsenic-contaminated soil depends on how much arsenic is dissolved in the gastrointestinal tract. Aluminum oxides are common components in the soil and act as a sink for arsenic. Knowledge of the behavior of arsenic associated with aluminum oxide surfaces in a simulated gastrointestinal tract will provide an understanding of the ingestion risk of arsenic-contaminated soil to humans. Abstract. Arsenate adsorbed to oxide surfaces may influence the risk posed by incidental ingestion of arsenic-contaminated soil. Arsenate sorbed to corundum (α-Al2O3), a model Al oxide, was used to simulate ingested soil that has AsV sorbed to Al oxides. An in vitro assay was used to simulate the gastrointestinal tract and ascertain the bioaccessibility of arsenate bound to corundum. The surface speciation of arsenate was determined using extended X-ray absorption fine structure and X-ray absorption near edge structure spectroscopy. The arsenate sorption maximum was found to be 470 mg kg–1 and the surface speciation of the sorbed arsenate was inner-sphere binuclear bidenate. The AsV was found to only be bioaccessible during the gastric phase of the in vitro assay. When the sorbed AsV was <470 mg kg–1 (i.e., the sorption maxima) the bioaccessible As was below detection levels, but when sorbed AsV was ≥470 mg kg–1 the bioaccessible As ranged from 9 to 16%. These results demonstrate that the bioaccessibility of arsenate is related to the concentration and the arsenate binding capacity of the binding soil.

2005 ◽  
Vol 480-481 ◽  
pp. 21-26 ◽  
Author(s):  
L.J. Skipper ◽  
F.E. Sowrey ◽  
D.M. Pickup ◽  
R.J. Newport ◽  
K.O. Drake ◽  
...  

The formation of a carbonate-containing hydroxyapatite, HCAp, layer on bioactive calcium silicate sol-gel glass of the formula (CaO)0.3(SiO2)0.7 has been studied in-vitro in Simulated Body Fluid (SBF). Extended X-ray Absorption Fine Structure (EXAFS), X-ray Absorption Near Edge Structure (XANES), X-ray diffraction (XRD), and solid state nuclear magnetic resonance (NMR) measurements have been performed with results showing the formation of a significantly amorphous HCAp layer after less than 5 hours in solution.


Author(s):  
H. Ade ◽  
B. Hsiao ◽  
G. Mitchell ◽  
E. Rightor ◽  
A. P. Smith ◽  
...  

We have used the Scanning Transmission X-ray Microscope at beamline X1A (X1-STXM) at Brookhaven National Laboratory (BNL) to acquire high resolution, chemical and orientation sensitive images of polymeric samples as well as point spectra from 0.1 μm areas. This sensitivity is achieved by exploiting the X-ray Absorption Near Edge Structure (XANES) of the carbon K edge. One of the most illustrative example of the chemical sensitivity achievable is provided by images of a polycarbonate/pol(ethylene terephthalate) (70/30 PC/PET) blend. Contrast reversal at high overall contrast is observed between images acquired at 285.36 and 285.69 eV (Fig. 1). Contrast in these images is achieved by exploring subtle differences between resonances associated with the π bonds (sp hybridization) of the aromatic groups of each polymer. PET has a split peak associated with these aromatic groups, due to the proximity of its carbonyl groups to its aromatic rings, whereas PC has only a single peak.


1968 ◽  
Vol 20 (03/04) ◽  
pp. 384-396 ◽  
Author(s):  
G Zbinden ◽  
S Tomlin

SummaryAn in vitro system is described in which adhesion of blood platelets to washed and tannic acid-treated red cells was assayed quantitatively by microscopic observation. ADP, epinephrine and TAME produced a reversible increase in platelet adhesiveness which was antagonized by AMP. With Evans blue, polyanetholsulfonate, phthalanilide NSC 38280, thrombin and heparin at concentrations above 1-4 u/ml the increase was irreversible. The ADP-induced increase in adhesiveness was inhibited by sodium citrate, EDTA, AMP, ATP and N-ethylmaleimide. EDTA, AMP and the SH-blocker N-ethylmaleimide also reduced spontaneous platelet adhesion to red cells. No significant effects were observed with adenosine, phenprocoumon, 5-HT, phthalanilide NSC 57155, various estrogens, progestogens and fatty acids, acetylsalicylic acid and similarly acting agents, hydroxylamine, glucose and KCN. The method may be useful for the screening of thrombogenic and antithrombotic properties of drugs.


2016 ◽  
Vol 88 (7) ◽  
pp. 3826-3835 ◽  
Author(s):  
Bernhard Hesse ◽  
Murielle Salome ◽  
Hiram Castillo-Michel ◽  
Marine Cotte ◽  
Barbara Fayard ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Anita Virtanen ◽  
Outi Huttala ◽  
Kati Tihtonen ◽  
Tarja Toimela ◽  
Tuula Heinonen ◽  
...  

<b><i>Objective:</i></b> To determine the direct effect of pravastatin on angiogenesis and to study the interaction between pravastatin and maternal sera from women with early- or late-onset pre-eclampsia (PE), intrauterine growth restriction, or healthy pregnancy. <b><i>Methods:</i></b> We collected 5 maternal serum samples from each group. The effect of pravastatin on angiogenesis was assessed with and without maternal sera by quantifying tubule formation in a human-based in vitro assay. Pravastatin was added at 20, 1,000, and 8,000 ng/mL concentrations. Concentrations of angiogenic and inflammatory biomarkers in serum and in test medium after supplementation of serum alone and with pravastatin (1,000 ng/mL) were measured. <b><i>Results:</i></b> Therapeutic concentration of pravastatin (20 ng/mL) did not have significant direct effect on angiogenesis, but the highest concentrations inhibited angiogenesis. Pravastatin did not change the levels of biomarkers in the test media. There were no changes in angiogenesis when therapeutic dose of pravastatin was added with maternal sera, but there was a trend to wide individual variation towards enhanced angiogenesis, particularly in the early-onset PE group. <b><i>Conclusions:</i></b> At therapeutic concentration, pravastatin alone or with maternal sera has no significant effect on angiogenesis, but at high concentrations the effect seems to be anti-angiogenic estimated by in vitro assay.


Sign in / Sign up

Export Citation Format

Share Document